CompoAtlas

LIBIFEME® Meno 50+ (2018.)

Food supplement registered in Latvia

Register snapshot dated 2 May 2025. It does not establish the current status of the product.

Number published by PVD
0000269/2022
Type
Food supplement
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
YFARMA SA
Manufacturer
Lecifarma-Laboratorio farmaceutico, Ltd
Origin
Portugāle
Register snapshot
2 May 2025
Recommended daily intake (Latvian text)
1 tablete dienā
Published pack size
tabletes pa 553mg
Published packaging
10 vai 30 tabletes

This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

The foreign register category does not determine the regulatory category of the product in France.

Published composition

Published namePublished text and quantityRecognised ingredientRole or context
C VITAMĪNSvitamins ; C VITAMĪNS ; 80 ; mgVitamine CVitamin or mineral
E VITAMĪNSvitamins ; E VITAMĪNS ; 12 ; mg α-TEVitamine EVitamin or mineral
Sējas linu sēklu sausais ekstrakts 45:1plants ; Sējas linu sēklu sausais ekstrakts 45:1 ; Linum usitatissimum ; ekstrakts ; 100 ; mglinum usitatissimumPlant
Drīveldriķa sakņu sausais ekstrakts 4:1plants ; Drīveldriķa sakņu sausais ekstrakts 4:1 ; Ferula assa-foetida L. ; ekstrakts ; 92 ; mgferula assa-foetidaPlant
Kaperkrūma augļu sausais ekstrakts 4:1plants ; Kaperkrūma augļu sausais ekstrakts 4:1 ; Capparis spinosa L. ; ekstrakts ; 44,5 ; mgcapparis spinosaPlant
194foodAdditives ; 194Not recognisedRole not identified
10foodAdditives ; 10Not recognisedRole not identified
202foodAdditives ; 202Not recognisedRole not identified
205foodAdditives ; 205Not recognisedRole not identified
258foodAdditives ; 258Not recognisedRole not identified

Quantities are reproduced as published. The export does not specify their basis: the recommended daily intake cannot be used to calculate a daily dose. No daily dose is estimated. Latvian names are retained without translation.

Manufacturer countries

Portugāle

French and European references for recognised ingredients

Unrecognised ingredients are not assessed. The absence of a signal does not establish product compliance.

Official source

View the official register

Official PVD export

Internet Archive copy dated 3 May 2025

PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.

CC0 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Sējas linu sēklu sausais ekstrakts 45:1
    Read the warning, when it applies and the studies cited

    FLAXSEED - LINUM USITATISSIMUM

    Route of administration: Oral

    Cautions and warnings

    Applies to products providing 5 g or more of flaxseed per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician immediately if you experience chest pain, vomiting, or difficulty swallowing or breathing after taking this product (EMA 2015).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes or a lazy bowel (EMA 2015; ESCOP 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Laxative; Promotion of bowel movement; Constipation.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (Pray 2006; Repchinsky 2002).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Applies to products providing 5 g or more of flaxseed per day.

    Do not use if you have difficulty swallowing (EMA 2015; ESCOP 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have fever or any undiagnosed gastrointestinal trouble (EMA 2015; Gardner and McGuffin 2013; Brinker 2010; ESCOP 2003).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occurs (EMA 2015; León et al. 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 26 July 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line